Sequential BioSciences

Sequential BioSciences is currently studying Hck-specific small molecule inhibitors and metabolically-targeted drug-drug conjugates following traditional chemotherapy being used today by Oncologists.

biotechnology company, oncology,therapy, resistance, cancer resistance, molecule inhibitors, sequential therapies, metabolically, targeted drug-drug, conjugates, chemotherapy, cancer, treatment


Last Update: MEZ/CET 24.09.2017, 01:35:20 Uhr | BACK TO HOMEPAGE